Mon, Nov 25, 2024 11:47 AM
Paras Defence hit 5% upper circuit as it opens new optical systems facility
A Flip by Avya Verma
Reported Consolidated quarterly numbers for Marksans Pharma are: Net Sales at Rs 641.92 crore in September 2024 up 20.84% from Rs. 531.24 crore in September 2023. Quarterly Net Profit at Rs. 96.72 crore in September 2024 up 15.8% from Rs. 83.52 crore in September 2023. EBITDA stands at Rs. 146.74 crore in September 2024 up 10.38% from Rs. 132.94 crore in September 2023.
Open Flip
Reported Consolidated quarterly numbers for India Finsec are: Net Sales at Rs 18.03 crore in September 2024 up 13.63% from Rs. 15.87 crore in September 2023. Quarterly Net Profit at Rs. 4.52 crore in September 2024 up 150.96% from Rs. 1.80 crore in September 2023. EBITDA stands at Rs. 13.20 crore in September 2024 up 27.41% from Rs. 10.36 crore in September 2023.
Open Flip
Reported Consolidated quarterly numbers for Orchid Pharma are: Net Sales at Rs 222.70 crore in September 2024 up 12.05% from Rs. 198.76 crore in September 2023. Quarterly Net Profit at Rs. 27.24 crore in September 2024 up 37.53% from Rs. 19.80 crore in September 2023. EBITDA stands at Rs. 37.86 crore in September 2024 up 19.55% from Rs. 31.67 crore in September 2023.
Open Flip
